Real-time enrollment status for this hidradenitis suppurativa (hs) clinical trial
Current Status
Recruiting
Checked: November 9, 2026 at 8:53 PM UTC
| NCT Number | NCT07783542 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa (HS) |
| Phase | PHASE2 |
| Target Enrollment | 200 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Oruka Therapeutics, Inc. |
| Last Updated on CT.gov | October 29, 2026 (1 week ago) |
As of November 9, 2026: Clinical trial NCT07783542 is currently recruiting participants. This phase2 study for hidradenitis suppurativa (hs) is actively seeking new participants at 20 locations across the United States. The study is sponsored by Oruka Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07783542 is actively recruiting participants as of November 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07783542 was last updated 1 week ago (October 29, 2026). HelloStudys verifies this status automatically.